Spectroscopic changes associated with mild cognitive impairment and dementia in parkinson's disease

Dementia and Geriatric Cognitive Disorders

Volumn 34, Issue 5-6, 2013, Pages 312-318

  Pagonabarraga, Javier ^a,d   Gómez Ansón, Beatriz ^b,e   Rotger, Ramon ^b,c   Llebaria, Gisela ^a,d,e   García Sánchez, Carmen ^a,d   Pascual Sedano, Berta ^a,d   Gironell, Alexandre ^a,d   Delfino, Manuel ^c   Ruscalleda, Jaume ^b   Kulisevsky, Jaime ^a,d,e  

^a Movement Disorders Unit   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Hippocampus; Parkinson's disease; Prefrontal cortex; Proton magnetic resonance spectroscopy

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; COGNITION; DEMENTIA; DISEASE COURSE; DISEASE DURATION; EXECUTIVE FUNCTION; HIPPOCAMPUS; HUMAN; MATTIS DEMENTIA RATING SCALE; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; MOVEMENT DISORDER SOCIETY; NEUROPSYCHOLOGY; PARKINSON DISEASE; PARKINSON DISEASE COGNITIVE RATING SCALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; TEMPORAL LOBE; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL MEMORY; WORKING MEMORY;

AGED, 80 AND OVER; ASPARTIC ACID; BRAIN CHEMISTRY; COGNITION; DATA INTERPRETATION, STATISTICAL; DEMENTIA; DISEASE PROGRESSION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; TEMPORAL LOBE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84870291982     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000345537     Document Type: Article

References (39)

1. Hely MA, Reid WG, Adena MA, et al: The Sydney Multicenter Study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
2. Muslimovic D, Post B, Speelman JD, Schmand B: Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
3. Halliday G, Hely M, Reid W, Morris J: The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008;115:409-415.
4. Aarsland D, Bronnick K, Williams-Gray C, et al: Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010;75:1062-1069.
5. Janvin CC, Larsen JP, Aarsland D, Hugdahl K: Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006;21:1343-1349.
6. Muslimovic D, Post B, Speelman JD, et al: Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008;70:2241-2247.
7. Schrag A, Jahanshahi M, Quinn N: What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
8. Galvin JE: Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord 2006; 20:302-310.
9. Pagonabarraga J, Kulisevsky J, Llebaria G, et al: Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord 2008;23:998-1005.
10. Whittington CJ, Podd J, Kan MM: Recognition memory impairment in Parkinson's disease: power and meta-analyses. Neuropsychology 2000;14:233-246.
11. Williams-Gray CH, Evans JR, Goris A, et al: The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the Cam- PaIGN cohort. Brain 2009;132:2958-2969.
12. Nagano-Saito A, Washimi Y, Arahata Y, et al: Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005;64:224-229.
13. Colloby S, O'Brien J: Functional imaging in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17: 158-163.
14. Benarroch EE: N-acetylaspartate and Nacetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008;70: 1353-1357.
15. Seppi K: MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice. Parkinsonism Relat Disord 2007; 13(suppl 3):S400-S405.
16. Summerfield C, Gomez-Anson B, Tolosa E, et al: Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study. Arch Neurol 2002;59:1415-1420.
17. Griffith HR, den Hollander JA, Okonkwo OC, et al: Brain N-acetylaspartate is reduced in Parkinson disease with dementia. Alzheimer Dis Assoc Disord 2008;22:54-60.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
19. Grosset K, Needleman F, Macphee G, Grosset D: Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Mov Disord 2004;19:1370-1374.
20. Hughes CP, Berg L, Danziger WL, et al: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
21. Mattis S: Dementia Rating Scale: Professional Manual. Odessa, Psychological Assessment Resources, 1988.
22. Emre M, Aarsland D, Brown R, et al: Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22:1689-1707.
23. Schmidt R, Freidl W, Fazekas F, et al: The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology 1994; 44:964-966.
24. McKeith IG, Dickson DW, Lowe J, et al: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
25. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30: 672-679.
26. Aarsland D, Andersen K, Larsen JP, et al: Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
27. Passani LA, Vonsattel JP, Carter RE, Coyle JT: N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases. Mol Chem Neuropathol 1997;31: 97-118.
28. Tedeschi G, Litvan I, Bonavita S, et al: Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 1997;120:1541-1552.
29. Chaudhuri KR, Lemmens GM, Williams SC, et al: Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations. Parkinsonism Relat Disord 1996;2:63-67.
30. Camicioli RM, Korzan JR, Foster SL, et al: Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett 2004;354:177-180.
31. Taylor-Robinson SD, Turjanski N, Bhattacharya S, et al: A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metab Brain Dis 1999;14:45-55.
32. Hu MT, Taylor-Robinson SD, Chaudhuri KR, et al: Cortical dysfunction in non-demented Parkinson's disease patients: a combined 31P-MRS and 18FDG-PET study. Brain 2000;123:340-352.
33. Williams-Gray CH, Foltynie T, Brayne CE, et al: Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-1798.
34. McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D: Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease. Dement Geriatr Cogn Disord 2009;28:121-129.
35. Kenny ER, Burton EJ, O'Brien JT: A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with Lewy bodies. A comparison with Alzheimer's disease and Parkinson's disease with and without dementia. Dement Geriatr Cogn Disord 2008;26:218-225.
36. Johnson DK, Galvin JE: Longitudinal changes in cognition in Parkinson's disease with and without dementia. Dement Geriatr Cogn Disord 2011;31:98-108.
37. Pappata S, Santangelo G, Aarsland D, et al: Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology 2011;77:1357- 1362.
38. Piatt AL, Fields JA, Paolo AM, et al: Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia. J Clin Exp Neuropsychol 1999;21:435-443.
39. Tsapkini K, Frangakis CE, Hillis AE: The function of the left anterior temporal pole: evidence from acute stroke and infarct volume. Brain 2011;134:3094-3105.